Home Category Region Publishers About Us Contact Us
Japanese Korean Chinese
Home > Market Research Report > Biotechnology > Antibody & Immunity > European Therapeutic Monoclonal Antibody Markets
Category
Biotechnology (1524)
Antibody & Immunity (193)
Biomarker (168)
Biomaterials (56)
Biotechnology Equipment (349)
Gene Therapeutics & RNAi (104)
Genome-based Drug Discovery (204)
Molecular Targeted Therapeutics (51)
Personalized Medicine (57)
Regenerative Medicine (122)
Market Research Report

European Therapeutic Monoclonal Antibody Markets

Published by Frost & Sullivan
Published August, 2008 Product code 71250
Content info 81 Pages
Price
US $ 6500 Web Access (Regional License)
US $ 7000 Hard Copy & Web Access (Regional License)


European Therapeutic Monoclonal Antibody Markets published by Frost & Sullivan in August, 2008. This report consists of 81 Pages and the price starts from US $ 6500.

Introduction

Abstract

This research service analyses the market landscape, revenue potential, market dynamics and trends in the monocloanl antibodies market focussing on five major markets in Europe. It analyses five major therapeutic areas where these antibodies find its applications. Together it recommends strategies for the players in these markets to obtain best results in the European market.

Table of Contents

1 EXECUTIVE SUMMARY

  • Summary of the European Therapeutic Monoclonal Antibody Market
    • 1. Overview of the European Therapeutic Monoclonal Antibody Market

2 GLOSSARY OF TERMS

  • Abbreviations
    • 1. Abbreviations

3 INDUSTRY CHALLENGES

  • Key Industry Challenges
    • 1. Identification of Key Issues and Challenges Faced by the Industry

4 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET

  • Overview of the European Therapeutic Monoclonal Antibody Market
    • 1. Market Overview
    • 2. Scope and Segmentation
    • 3. Research Methodology
  • Measurements
    • 1. Measurements
  • Market Dynamics
    • 1. Market Drivers
    • 2. Market Restraints
  • Revenue Forecasts
    • 1. Revenue Forecasts for the Total European Market
  • Market Trends
    • 1. Technology Trends
    • 2. Product Trends
  • Competitive Structure
    • 1. Competitive Structure
    • 2. Market Share Analysis

5 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET FOR USE IN CANCER

  • Forecasts for the European Oncology Therapeutic Monoclonal Antibody Market
    • 1. Market Overview
    • 2. Measurements
    • 3. Currently Marketed Products
    • 4. Revenue Forecasts
    • 5. R&D Pipeline
    • 6. Competition

6 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET FOR USE IN AUTOIMMUNE AND INFLAMMATORY DISEASES

  • Forecast for the European Autoimmune and Inflammatory Disease Therapeutic Monoclonal Antibody Market
    • 1. Market Overview
    • 2. Measurements
    • 3. Currently Marketed Products
    • 4. Revenue Forecasts
    • 5. R&D Pipeline
    • 6. Competition

7 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET FOR USE IN ORGAN TRANSPLANT

  • Forecast for the European Organ Transplant Therapeutic Monoclonal Antibody Market
    • 1. Market Overview
    • 2. Measurements
    • 3. Currently Marketed Products
    • 4. Revenue Forecasts
    • 5. R&D Pipeline
    • 6. Competition

8 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET FOR USE IN CARDIOVASCULAR DISORDERS

  • Forecast for the European Cardiovascular Therapeutic Monoclonal Antibody Market
    • 1. Market Overview
    • 2. Measurements
    • 3. Currently Marketed Products
    • 4. Revenue Forecasts
    • 5. R&D Pipeline
    • 6. Competition

9 EUROPEAN THERAPEUTIC MONOCLONAL ANTIBODY MARKET FOR USE IN INFECTIOUS DISEASES

  • Forecast for the European Infectious DiseasesTherapeutic Monoclonal Antibody Market
    • 1. Market Overview
    • 2. Measurements
    • 3. Currently Marketed Products
    • 4. Revenue Forecasts
    • 5. R&D Pipeline
    • 6. Competition

10 MARKET ENGINEERING STRATEGIC RECOMMENDATIONS

  • Strategic Recommendations
    • 1. Strategic Recommendations for the European Therapeutic Monoclonal Antibody Market

11 DATABASE OF KEY INDUSTRY PARTICIPANTS

  • Key Industry Participants in the Market
    • 1. Key Industry Participants

12 DECISION SUPPORT DATABASES

  • Decision Support Databases for the Industry Participants
    • 1. Government Healthcare Expenditure
    • 2. Private Healthcare Expenditure
    • 3. Pharma R&D Expenditure
    • 4. Breast Cancer Incidence
    • 5. Colon Rectum Cancer Incidence
Back to Top